History

  • 1993

    Founded Ousheng Pharm. in Chengdu, starting business layout.

  • 2003

    Relocated production base from Chengdu to Beijing, constructed the Phase I project, and completed the adjustment of company core location.

  • 2006

    Obtained 4 Chinese patents for the core technology, as follows: ZL200610153091.8, ZL200610113725.7, ZL200610113984.X, ZL200610114125.2.

  • 2007

    Obtained Chinese patent for the core technology: ZL200710177989.3.

  • 2009

    Awarded the titles of "National High-Tech Enterprise" and "Zhongguancun High-Tech Enterprise", and has maintained both qualifications ever since.

  • 2009

    Gifted the world’s first fully automatic mechanical drilling machine from ALZA Corporation (U.S.A.) for controlled-release tablet testing.

  • 2011

    Started construction of the Phase II project of Beijing Huairou Plant officially, expanding local production.

  • 2019

    Invested in land acquisition in Zhenjiang, Jiangsu; launched new production base planning.

  • 2021

    RoToFier®、JUPOPINE®、JUPOSHU® passed the Consistency Evaluation of quality and efficacy of Generic Drugs, and JUPOPINE® was officially designated as “Nifedipine Controlled-Release Tablets”

  • 2021

    Zhenjiang plant held a groundbreaking ceremony and entered substantial construction.

  • 2022

    JUPOPHON® officially passed the Consistency Evaluation of quality and efficacy of Generic Drugs

  • 2024

    Obtained a utility model patent: ZL202420848264.1.

  • 2024

    Zhenjiang plant completed and inaugurated.

  • 2025

    Zhenjiang Plant officially started production, with the company's large-scale capacity fully achieved.